These results suggest that CK2 activity also regulates influenza virus budding.
Introduction
Influenza virus morphogenesis involves a number of steps that require the transport of viral components -the haemagglutinin (HA), neuraminidase (NA), matrix proteins (M1 and M2) and viral ribonucleoprotein (vRNP) -to the assembly site, interaction among the viral components, budding from the membrane and release of virus particles (reviewed in Nayak, 1996 Nayak, , 2000 Nayak & Barman, 2002 ; Nayak & Hui, 2002) . It is becoming evident that steps involved in these processes are regulated by host components. However, the role of host components, particularly in the budding process, is poorly understood. Recently, the concept of a virus budding process that is the topological reverse of endocytosis has been proposed for human immunodeficiency virus (HIV) and Ebola Author for correspondence : Debi P. Nayak.
Fax j1 310 2063865. e-mail dnayak!ucla.edu virus (Patnaik et al., 2000) . Furthermore, budding and particle release of HIV and other retroviruses appear to involve participation of the components of the vacuolar protein sorting pathway (for a review, see Freed, 2002) . Also, it has recently been shown that lipid rafts are involved in the budding process of many enveloped viruses including influenza virus (reviewed in Nayak & Barman, 2002) . We recently found that influenza virus budding is an active process and requires ATP hydrolysis ). Since ATP is involved in regulating many cellular processes, including membrane signalling and protein kinase (PK) activities, and since PKs have been shown to regulate different phases of the virus infectious cycle, we have investigated the role of G protein membrane signalling and PKs in influenza virus budding.
A family of heterotrimeric (αβγ) guanine nucleotide-binding regulatory proteins (G proteins) are involved in the regulation of transmembrane signal transduction (for a review see Helmreich, 2001 ). The G proteins operate by utilizing a guanine nucleotide-binding and -hydrolysing cycle. Agonistligand receptor interaction causes the exchange of guanosine 5h-diphosphate (GDP) for guanosine 5h-triphosphate (GTP) at the α subunit of the G protein (Gα) and leads to subsequent dissociation of Gα from the βγ subunit (Gβ and Gγ). This GTP-bound Gα is the active state of the G protein, which is terminated by hydrolysis of the bound GTP by an intrinsic GTPase activity. There is increasing evidence that heterotrimeric G proteins and PKs participate in the regulation of apical membrane dynamics such as membrane ruffling, endocytosis and exocytosis (reviewed in Ceresa & Schmid, 2000 ; Cavalli et al., 2001) . Moreover, Gα i , Gα o and GTPase activating protein GAP-43 are enriched in lipid rafts (Arni et al., 1998 ; Moffett et al., 2000) , regions on the apical plasma membrane that function as the budding site of influenza virus (Scheiffele et al., 1999 ; Barman & Nayak, 2000 ; Zhang et al., 2000 ; Barman et al., 2001) .
In the present study, we have investigated the role of G proteins and PKs in regulating influenza virus budding from the apical cell surface. Our results show that in WSN virusinfected Madin-Darby canine kidney (MDCK) cells, G protein signalling stimulators (such as fluorides, compound 48\80, mastoparan or GTP analogues) increased virus budding, and that G protein signalling blockers (suramin or NF023) decreased virus budding. In addition, the introduction of the casein kinase 2 (CK2) inhibitor 5,6-dichloro-1-β--ribofuranosylbenzimidazole (DRB), or CK2-immunodepleted cytosol into permeabilized cells inhibited virus budding, whereas inhibitors of protein kinase A (PKA), protein kinase C (PKC), or phosphatidylinositol 3-kinase (PI3K) did not affect virus budding.
Methods
Viruses and cells. All experiments were carried out using MDCK cells obtained from the ATCC and maintained in tissue culture medium containing Dulbecco's modified Eagle's medium (DMEM ; Gibco BRL) supplemented with 10 % heat-inactivated foetal bovine serum (FBS ; Atlanta Biologicals), 10 U\ml penicillin G and 10 µg\ml streptomycin and propagated at 37 mC in a 5% CO # -saturated atmosphere with a resulting pH of 7n4 in the tissue culture medium. Influenza virus strain A\WSN\33 (H1N1) was used in these experiments and prepared by infecting MDCK cells at an m.o.i. of 0n005 and incubating in virus growth medium containing minimum essential medium (MEM) supplemented with 0n2 % BSA, 0n075 % NaHCO $ and 0n0015 % DEAE-dextran at 37 mC. At 36 h post-infection (p.i.), culture fluids were harvested, clarified by centrifugation and then stored at k80 mC. Stock virus titre was 1i10) p.f.u.\ml.
Chemicals, drugs and peptides. All chemicals, drugs and peptides used in these experiments were purchased from Sigma or Calbiochem. Sodium fluoride (NaF), compound 48\80, suramin, NF023 and 8-bromoadenosine 3h,5h-cyclic monophosphate (8-Br-cAMP) were dissolved in water. H-89, LY294002 and DRB were dissolved in absolute ethanol. Ro-32-0432 and bisindolylmaleimide I (BIM) were dissolved in DMSO. The residual solvents (less than 1 %) had no toxic effect on the cell monolayer. Aluminium fluoride (AlF % − ) treatment on MDCK cells was performed as follows : (i) 40 µM aluminium chloride (AlCl $ ) plus 30 mM NaF (Brewer & Roth, 1995) or (ii) 50 µM aluminium ammonium sulfate [AlNH % (SO % ) # ] plus 10 mM potassium fluoride (KF) (Ikonen et al., 1996) . The GTP and GTP analogues guanosine 5h-O-(3-thiotriphosphate) (GTPγS) and 5h guanylylimidodiphosphate (GMP-PNP) were dissolved in serum-free DMEM just before use. G protein signalling activator mastoparan (INLKALAALAKKIL), PKA inhibitor 6-22 amide (TYADFI-ASGRTGRRNAI), PKC inhibitor peptide 19-36 (RFARKGALRQKNV-HEVKN) and CK2 substrate peptide (RRADDSDDDDD) were dissolved in water.
Virus infection and sample collection. For virus infection, MDCK cells were seeded at a cell density of 1n2i10' cells\35 mm dish and maintained in 2 ml of culture medium for 30 h. Prior to infection, cells were washed with PBS + (PBS plus 0n5 mM MgCl # and 1 mM CaCl # ). In all experiments, cells were infected with WSN virus at an input m.o.i. of 1 in virus dilution buffer (PBS + supplemented with 0n2 % BSA, 0n005 % DEAE-dextran, 10 U\ml penicillin G and 10 µg\ml streptomycin). After adsorption for 1 h at 37 mC, the residual unabsorbed virus was removed and cells were washed five times with DMEM containing 0n2 % BSA. The infected cells were incubated in 2 ml DMEM containing 0n2 % BSA for 13 h at 37 mC. Sialidase (NA ; final concentration 0n1 mU\ml) was added 2n5 h prior to removal of culture medium. Infected cells were then washed five times with 2 ml of DMEM containing 0n2 % BSA to remove residual virus. The fifth wash was collected as the experimental background. The new medium, with or without the drug, was added and harvested after a 15 min or 1 h incubation for the virus assay.
LPC permeabilization of filter-grown MDCK cells. The lysophosphatidylcholine (LPC) permeabilization method was carried out as described previously . Briefly, MDCK cells (1n2i10') were seeded on Transwells (24 mm diameter, 3n0 µm pore size ; Costar), infected with WSN virus at an m.o.i. of 1 and incubated for 13 h. The Transwell filters containing the cell monolayers were permeabilized from the basal side by LPC (Avanti Polar Lipids). The Transwells were then washed and treated with DMEM with or without GTP analogues from the basal chamber for 20 min at 37 mC. Subsequently, the Transwells were incubated with 1n5 ml DMEM with 0n2% BSA and 2n5 ml DMEM in the upper and lower compartments, respectively, and virus released in the upper chamber after 15 min was assayed.
Plaque assay. Determination of the amount of influenza virus released from infected cells into the medium was carried out by plaque assay on monolayers of MDCK cells in 35 mm tissue culture dishes using 2 ml agar overlay MEM supplemented with 0n6 % low melting point agarose, 0n075 % NaHCO $ and 0n0015 % DEAE-dextran. Visible plaques were counted after 3 days at 33 mC and p.f.u.\ml were calculated.
Western blotting. Proteins were resolved by SDS-PAGE (10 % gel) and transferred electrophoretically to Trans-Blot nitrocellulose membrane (Bio-Rad). Membranes were blocked in 1 % blocking solution and probed with anti-CK2α monoclonal antibodies (Santa Cruz Biotechnology ; diluted 1 : 500) overnight at 4 mC. The membrane was then incubated with anti-mouse monoclonal antibodies (diluted 1 : 1200) for 1 h at room temperature and antigens finally visualized on film by enhanced chemiluminescence (ECL ; Amersham Biosciences).
Digitonin permeabilization of filter-grown MDCK cells.
Digitonin permeabilization of the basal membrane of MDCK cells was carried out as described by Esparı! s-Ogando et al. (1994) , and the cytosol support of permeabilized MDCK cells was carried out according to the procedures of Pimplikar et al. (1994) and Ikonen et al. (1996) . Briefly, MDCK cells were seeded, grown and infected on the Transwell as DAFG Influenza virus budding Influenza virus budding described previously ). The Transwell filters containing the cell monolayers were permeabilized from the basal side with digitonin (250 µg\ml) for 15 min at room temperature. The Transwells were washed twice with PBS + on the apical side and with transport medium [115 mM potassium acetate (KOAc), 25 mM HEPES, pH 7n4, 2n5 mM MgCl # , 1 mM DTT, 5 mM EGTA and 2n5 mM CaCO $ ] on the basal side. Cells were then incubated with 250 µl (2 mg) of HeLa or MDCK cytosol with or without an ATP-regenerating system (1 mM ATP, 8 mM phosphocreatine and 50 µg\ml creatine phosphokinase) in the basal chamber and with PBS + containing 0n1 mU\ml NA in the upper compartment. After 45 min at 37 mC incubation, the upper compartment was washed five times and the fifth wash was collected for the experimental background. The Transwells were then incubated with 0n5 ml DMEM plus 0n2 % BSA in the upper compartment and with cytosol in the lower compartment and virus released into the upper chamber after 15 min was assayed.
Permeabilization assessment. The effectiveness of permeabilization was assessed by the cell viability assay (trypan blue uptake) and the release of cytosolic lactate dehydrogenase (LDH) from the basal side as previously described ).
Preparation of HeLa cytosol. The preparation of HeLa cytosol was carried out as described previously (Pimplikar et al., 1994) . Briefly, HeLa cells were grown in suspension in Eagle's Minimal Essential Medium (S-MEM ; Sigma) supplemented with 1 g\l glucose and 10 % newborn calf serum (Gemini Bio-Products) to a density of 4i10&\ml. Cells were pelleted by centrifugation, washed with ice-cold PBS and resuspended in cold HeLa swelling buffer (1 mM MgCl # , 1 mM DTT, 1 mM EGTA and 1 µM cytochalasin D). After swelling for 5 min on ice, cells were centrifuged, the supernatant removed, protease inhibitor cocktail (Sigma) added and the cells broken by a glass Dounce homogenizer with 10 strokes. Finally, 1\10 volume of 10i KOAc buffer (1i KOAc buffer : 115 mM KOAc, 25 mM HEPES, pH 7n4, 2n5 mM MgCl # and 10 mM DTT) was added to the homogenate and further homogenized with 20 strokes. Using this procedure, 80 % of the cells were broken, as judged by light microscopy. The homogenate was centrifuged at 14 000 g for 10 min followed by another centrifugation at 171 000 g for 90 min. The supernatant was frozen in small aliquots at k80 mC. This procedure routinely yielded " 14 ml containing " 12n5 mg\ml cytosolic protein from 10 l of cell suspension.
Preparation of MDCK cytosol. The preparation of MDCK cytosol was carried out as described previously (Ikonen et al., 1996) . Confluent MDCK monolayers from 40 150 cm# dishes (total 7i10) cells) were trypsinized. Trypsin was then inactivated by first resuspending the cells in culture medium containing 10 % FBS, pelleting and washing again with 30 ml of ice-cold PBS supplemented with 1 mg\ml soybean trypsin inhibitor. The cell pellet was resuspended in cold MDCK swelling buffer (1 mM MgCl # and 1 mM EGTA) and incubated on ice for 10 min. After pelleting the cells, a protease inhibitor cocktail containing cytochalasin D (final concentration 1 µM) and DTT (final concentration 1 mM) was added and the cells broken by sonication. The solution containing cell fragments was then adjusted to an isotonic condition by adding 1\10 vol. of 10i KOAc stock. Following a 20 min centrifugation at 600 g at 4 mC, the supernatant was further centrifuged for 1 h at 200 000 g at 4 mC. The cytosol (" 2n5 ml) containing " 12 mg\ml protein was aliquoted and stored at k80 mC.
Immunodepletion of CK2.
To deplete CK2, 150 µg anti-CK2α antibody was coupled to 0n1 g protein A-Sepharose beads (Amersham Biosciences) in PBS by mixing for 2 h at 4 mC. The beads were then washed with PBS and incubated with cytosol (10 mg) overnight on ice with intermittent mixing. After removing the beads by centrifugation, the cytosol was used in a digitonin permeabilization assay. The depletion was monitored by determining the loss of CK2 activity.
Preparation of membranes and cytosol from MDCK cells for assaying enzymatic activity. The membranous and cytosolic fraction of MDCK cells was prepared by a modification of a previously described method (Hansen & Casanova, 1994) . Briefly, MDCK cells were rinsed and scraped off in PBS, pelleted in a microfuge and resuspended in 1 ml of icecold 3 mM imidazole (pH 7n4) and 300 mM sucrose. The resuspended cells were passed at least 40 times through a 25-gauge syringe. Greater than 90 % of the cells were lysed under these conditions, as assessed by trypan blue staining. The nuclei and cell debri were then pelleted by centrifugation at 14 000 g for 5 min and the supernatant further centrifuged at 105 000 g for 1 h. The pellet and supernatant were taken to represent membrane and cytosolic fractions, respectively.
PKC activity assay. PKC activity assays were performed as described previously (Hui & Yung, 1992 ; Yung et al., 1994) . The reaction mixture (25 µl) containing 30 mM Tris-HCl buffer, pH 7n5, 6 mM magnesium acetate, 0n25 mM EGTA, 0n4 mM CaCl # , 40 µg\ml phosphatidylserine, 8 µg\ml dioleoylglycerol, 1 mg\ml histone IIIS, 0n12 mM [γ-$#P]ATP (Perkin-Elmer Life Sciences) and membrane or cytosol fractions containing 10 µg of protein were incubated at 30 mC for 8 min. Phosphorylated substrates were quantified as described (Huang & Huang, 1991) . Twenty µl of the reaction mixture was spotted on to a line of origin (1n5 cm from the bottom) on an instant thin-layer chromatography strip (1i9n5 cm, type SG ; Gelman Sciences), which had previously been spotted with ATP (50 mM) in 15 % trichloroacetic acid (TCA). After chromatography for 6 min at room temperature in a beaker containing 5 % TCA and 0n2 M KCl, the strips were air dried and the origin (1n5 cm above the line of origin) excised for counting in a scintillation counter. CK2 activity assay. Assays for CK2 activity were performed as described previously (Perich et al., 1992) . Briefly, 50 µl of reaction mixtures containing 50 mM Tris-HCl, pH 7n5, 12 mM MgCl # , 100 mM NaCl, 1 mM CK2 peptide substrate, 25 µM [γ-$#P]ATP and 10 µg isolated protein (membrane or cytosol) were incubated at 30 mC for 8 min. Reactions were stopped by adding 60 µl 10 % TCA and 10 µl BSA and incubated on ice for 10 min. The precipitated protein was removed by centrifugation and 12 µl of supernatant was spotted on to pieces of P81 phosphocellulose (Whatman Int.). The phosphocellulose pieces were washed with an excess of 75 mM phosphoric acid, air dried and counted in a scintillation counter.
Statistical analysis.
The results were obtained from at least three separate experiments, each using triplicate culture plates in each experiment. Unless otherwise specified, all data were expressed as meanpstandard deviation (SD) of n values (number of experiments) and where SD bars are not apparent, the SD value was less than the symbol used. The significance of the difference (P) between values was compared using the Student's t-test, and P 0n05 or less was considered significant.
Results

G protein-acting drugs alter virus budding
To investigate the role of G proteins in the regulation of influenza virus budding, MDCK cells were infected at an m.o.i. of 1 and incubated without drugs for 13 h, when optimal virus budding occurred . At 13 h p.i., infected Table 1 ). *P 0n05, **P 0n001 vs mock treatment.
cells were washed and treated with or without drugs for 15 min. Initially, we examined the role of stimulators of G protein signalling to test whether these compounds had any effect on influenza virus budding from MDCK cells. NaF and AlF − % directly activate G protein by mimicking the γ-phosphate of GTP (Bigay et al., 1985 ; Garcia et al., 1991) . Compound 48\80, analogous to G-protein-coupled receptor, activates G protein (probably interacting with Gα i ) (Mousli et al., 1990) . Mastoparan, a membrane-permeable amphiphilic tetradecapeptide toxin from wasp venom, activates Gα o and Gα i by increasing the hydrolysis and binding of GTP to the Gα and small G proteins Rho\Rac, but is less potent with Gα s , Gα t , Gα z , Gα q and Ras (Higashijima et al., 1990 ; Koch et al., 1991) . Our results showed that compared with mock treatment, the treatment of 10 or 50 mM NaF, 40 or 50 µM AlF − % , 1 or 10 µg\ml compound 48\80 and 50 or 250 µM mastoparan increased the 15 min virus budding rate two-to fivefold to 268p35 %, 329p21 %, 193p23 %, 222p40 %, 191p19 %, 300p21 %, 218p8 % and 555p38 %, respectively (Fig. 1A, Table 1 ).
To test whether the effect could be reversed in the presence of G protein signalling blockers, we measured the virus budding rate after the addition of suramin or NF023. Both suramin and NF023 inhibit GDP-GTP exchange on the Gα subunit (Beindl et al., 1996 ; Freissmuth et al., 1996) . Suramin also inhibits membrane ruffling on MDCK cells (Dowrick et al., 1993) . As shown in Fig. 1(B) , virus budding was decreased in the presence of G protein signalling blockers. After the treatment with 200 or 750 µg\ml suramin and 3 or 30 µM NF023, the virus budding rate was reduced to 86p2%, 64p6%, 84p6 % and 80p3 %, respectively, of that of the mock-treated cells (Fig. 1B, Table 1 ).
GTP analogues in LPC-permeabilized infected cells increase virus budding
The results of the above experiments strongly suggested that GTP plays an important role in influenza virus budding. To examine the role of GTP analogues, we used basolateralsurface LPC-permeabilized MDCK cells , since GTP and the GTP analogues GTPγS (hydrolysis-resistant GTP analogue) and GMP-PNP (non-hydrolysable GTP analogue) cannot gain entry into intact cells (Cockcroft & Gomperts, 1985) . MDCK cells were grown and infected on a supporting microporous membrane and permeabilized by LPC from the basolateral surface ). Permeabilized cells were then incubated with 1 mM GTPγS or GMP-PNP, which keep the G protein in an active state because they can bind but are not hydrolysed (Terry et al., 1995) . The results showed that the virus budding rate after treatment with GTPγS and GMP-PNP in LPC-permeabilized cells increased to 147p16 % and 178p27 %, respectively, compared with 100 % in LPC-permeabilized cells with mock treatment (Fig. 2) . The enhancing effect of GTPγS and GMP-PNP could be competitively inhibited by the presence of excess GTP. A high concentration of GTP (10 mM) decreased the virus budding rate for both GTPγS and GMP-PNP to 102p3 % and 99p7%, respectively (Fig. 2) . Taken together, these results suggest that G protein signalling is involved in regulating the influenza virus budding process.
PKA inhibitor and activator do not alter virus budding
In Fig. 1(A) , NaF and AlF − % , which stimulate G protein signalling, increased virus budding. However, fluoride ion (F − ) has previously also been shown to increase the level of adenosine 3h,5h-cyclic monophosphate (cAMP) in MDCK cells (Eker et al., 1994) . Since our previous findings indicated that ATP was a key molecule involved in regulating virus budding , we wanted to determine whether PKs and phosphorylation play an important role in the process of influenza virus budding. Moreover, PKA is a cAMP-dependent Helmreich, 2001) . Therefore, to test whether the budding process was affected by PKA, we treated the infected MDCK cells with the highly specific and membrane-permeable PKA inhibitor H89, which decreases the PKA activity, or with the phosphodiesterase-resistant cAMP analogue 8-Br-cAMP, which increases the cAMP level and in turn enhances PKA activity. In addition, 8-Br-cAMP has been shown to stimulate apical endocytosis in MDCK cells (Eker et al., 1994) . However, neither H89 (100 and 500 nM) nor 8-BrcAMP (0n1 and 1 mM) had any significant effect on virus budding (Table 1 ). These data indicate that PKA does not play a significant role in influenza virus budding.
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PKC inhibitors do not alter virus budding
PKC is a large superfamily of related PKs, which carry out diverse regulatory roles in many cellular processes (for a review, see Pears, 1996) . PKC has been shown to be involved in plasma membrane dynamics such as membrane ruffling and endocytosis (reviewed in Ceresa & Schmid, 2000) . Therefore, we treated the infected MDCK cells with the highly specific membrane-permeable PKC inhibitors such as BIM or Ro-32-0432. However, neither BIM (50 and 200 nM) nor Ro-32-0432 (50 and 200 nM) exhibited any significant effect on virus budding (Table 1) Samples from the apical chamber were collected and virus titres were determined by p.f.u. assay. Results are presented as the percentage of mock-treated non-permeabilized cells (100 %). Data represent meanpSD (n l 3). *P 0n001 vs mock treatment on LPC-permeabilized cells. Table 1 ). *P 0n05, **P 0n001 vs mock treatment.
shown). Although PKC has been shown to play a role in influenza virus mRNA translation (Kurokawa et al., 1990 ) and virus entry (Root et al., 2000) , our data indicate that, like PKA, PKC does not play a significant role in influenza virus budding.
PI3K inhibitors do not alter virus budding
Besides PKC, PI3K has been found to regulate various steps in endocytic trafficking (for a review, see Ridley, 2001) . Therefore, we treated the infected MDCK cells with the highly specific membrane-permeable PI3K inhibitors, LY294002 and wortmannin. However, neither LY294002 (5 and 20 µM) nor wortmannin (25 and 50 nM) had any significant effect on virus budding (Table 1 ). These data indicate that PI3K does not play a significant role in influenza virus budding.
CK2 inhibitor decreases virus budding
Previous studies have indicated that CK2 activity is associated with influenza virus particles (Tucker et al., 1990 ; for a review, see and that the viral PA protein in the influenza polymerase complex is phosphorylated by CK2 (Sanz-Ezquerro et al., 1998 ; Perales et al., 2000) . Therefore, we wanted to know whether the CK2 plays any role in virus budding. When virus-infected cells were treated with the
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Table 2. Rate of virus budding after treatment of digitonin-permeabilized MDCK cells with peptides
The numbers in parentheses represent the number of independent experiments. Experiments were done out as shown in Fig. 5(A) .
Peptide Digitonin permeabilized
Cytosol ATP-regeneration system* CK2 † PKA ‡ PKC § Budding rate after 15 min
* ATP-regeneration system in cytosol : 1 mM ATP, 8 mM phosphocreatine and 50 µg\ml creatine phosphokinase. † CK2 substrate peptide (RRADDSDDDDD), K m l 19 µM (Marin et al., 1994) . ‡ PKA inhibitor 6-22 amide (TYADFIASGRTGRRNAI), K i l 1n7 nM (Cheng et al., 1986) . § PKC inhibitor peptide 19-36 (RFARKGALRQKNVHEVKN), K i l 147 nM (House & Kemp, 1987) . R P 0n05 and FP 0n001 vs mock treatment on digitonin-permeabilized cells (with HeLa cytosol and ATPregeneration system).
membrane-permeable CK2 inhibitor DRB at different concentrations (5, 10 and 50 µM) for 15 min or 1 h, the virus budding rate from MDCK cells decreased with increasing concentrations of DRB (Fig. 3 , Table 1 ). CK2 activities in infected and uninfected cells after treatment with 50 µM DRB were determined in parallel and the results indicated that both the cytosolic and membranous CK2 activities decreased in virusinfected cells after DRB treatment (data not shown) and corresponded to the decrease in virus budding. We next examined whether CK2 activity changed during the virus infectious cycle. The CK2 activity assay indicated that both the cytosolic and membranous CK2 activities increased during influenza virus infection (Fig. 4A, B) . It should be noted that the maximum increase in CK2 activity was observed around 15 h p.i., which is consistent with the time of maximum virus budding ). CK2 is a tetramer composed of two types of subunit with the general structure α # β # or ααhβ # (reviewed in Allende & Allende, 1995) . The α (42-44 kDa) and αh (38 kDa) subunits are catalytic subunits, whereas the β (26-41 kDa depending on cell type) subunit is a regulatory subunit. By Western blot analysis of the CK2α subunit, we did not find any significant change in the amount of CK2α subunit in infected MDCK cells (Fig. 4C) . However, we failed to detect CK2αh subunit in MDCK cells by Western blotting (data not shown), suggesting that MDCK cells do not express the CK2αh subunit. These data indicate that the enzymatic activity, but not expression of the CK2 protein, was stimulated during influenza virus infection.
CK2 substrate peptides in digitonin-permeabilized infected cells decrease virus budding
Since the above results suggested that CK2, but not PKA, PKC or PI3K, was involved in the influenza virus budding process, we wanted to determine whether the CK2 substrate peptide could compete with and decrease virus budding. Therefore, we developed an in vivo digitonin-permeabilized MDCK cell system to assay virus budding in the presence of peptide. Accordingly, cells were grown and infected on a supporting microporous membrane and treated with digitonin from the basolateral surface as described in Methods. The digitonin treatment rendered approximately 80 % of MDCK cells permeable as measured by accessibility to trypan blue when applied from the basal side but not from the apical side (data not shown). The permeability after digitonin treatment was also assayed by determining the release of cytosolic marker LDH from cells into the medium. The results showed that 55p5 % of total LDH was released into the medium (data DAGB E. K.-W. Hui and D. Nayak E. K.-W. Hui and D. Nayak Fig. 5 . Inhibitory effect of CK2 substrate peptides in cytosol and CK2-immunodepeleted cytosol on virus budding. (A) Filter-grown MDCK cells were infected and permeabilized at 13 h p.i. by digitonin as described in Methods. Permeabilized cells were incubated with HeLa cytosol with or without an ATP-regeneration system (HeLapATP) and with or without peptides (CK2, CK2 substrate peptides ; PKA, PKA inhibitor 6-22 amide ; PKC, PKC inhibitor peptide 19-36) for 45 min. Cells were then washed further and incubated for 15 min with or without peptides (as described in Methods). Samples from the apical chamber were collected and virus titres were determined by p.f.u. assay. Data represent meanspSD (n l 3). *P 0n05, **P 0n001 vs mock treatment on digitonin-permeabilized cells with ATP regeneration system. (B) Digitoninpermeabilized cells were incubated with mock-depleted (j), or normal mouse-serum-depleted (mS), or CK2α-immunodepleted (kCK2α) HeLa cytosol (with ATP-regeneration system). Results are presented as the percentage of virus release from permeabilized cells treated with mockdepleted HeLa cytosol (100 %). Data represent meanpSD (n l 3). *P 0n001 vs mock-depleted cytosol. not shown). This degree of LDH release is similar to permeabilization by streptolysin O treatment, which causes more than 50 % LDH release into the medium (Pimplikar et al., 1994) , but is different from permeabilization by LPC treatment, which releases only a small fraction (" 8 %) of intracellular LDH ). Because of the loss of cytosolic proteins after digitonin treatment, we supported the permeabilized cells by supplementing with the cytosol fraction and energy regeneration system from the basolateral side.
To determine the effect of CK2 peptide on virus budding, MDCK cells were grown on the membrane and infected with WSN virus at an m.o.i. of 1. At 13 h p.i., cells were permeabilized by digitonin and incubated with HeLa cytosol with CK2 substrate peptide or PKA inhibitor 6-22 amide or PKC inhibitor peptide 19-36. For studying virus budding in digitonin-permeabilized MDCK cells, we routinely used HeLa cytosol because it was easy to prepare. The HeLa cytosol was comparable with MDCK cytosol, since the virus budding efficiency was similar between these two cytosols ( Table 2) . The results showed that the 15 min virus budding rate after incubation with 20 or 100 µM CK2 substrate peptides in digitonin-permeabilized cells decreased to 65p5 % and 56p 4 %, respectively, compared with 80p5 % after mock treatment (Fig. 5A, Table 2 ). Again, treatment with 20 or 200 nM PKA and 2 or 20 µM PKC inhibitor peptides did not significantly affect virus budding (79p7%, 78p11 %, 83p8% and 81p6 %, respectively ; Fig. 5A , Table 2 ), supporting the results observed early (Table 1) .
Virus budding is affected by depletion of CK2
Since the digitonin-permeabilization system requires the support of the cytosolic fraction, specific protein could be removed by immunodepletion using specific antibodies and thereby permitting investigation of the function of the protein in virus budding. Therefore, we treated HeLa cytosol with normal mouse serum or with anti-CK2α antibodies to remove CK2 and confirmed the decrease in CK2 activity in immunodepleted HeLa cytosol by CK2 enzymatic activity assay. Only 48 % (2n1 nmol $#P\mg protein\min) of CK2 activity was present in immunodepleted cytosols compared with 100 % (4n4 nmol $#P\mg protein\min) in mock-depleted cytosol (data not shown), indicating at least 50 % depletion of CK2 from HeLa cytosol after treatment with anti-CK2α antibody. The immunodepleted cytosol was shown to inhibit the virus budding by " 50 % compared with mock-treated cytosol in digitonin-permeabilized MDCK cells (Fig. 5B) , further confirming the regulatory role of CK2 activity in influenza virus budding.
Discussion
Influenza virus binds to the cell surface sialic acid receptors, becomes internalized by receptor-mediated endocytosis and vRNP is released from the endosome in the acid environment by membrane fusion and dissociation of M1 from vRNP. M1-free vRNP is then translocated into the host nucleus where mRNA transcription and vRNA (vRNP) replication occur. vRNPs are exported from the nucleus into the cytoplasm and subsequently all viral components, namely vRNP, M1 and the viral envelope containing selected host lipids and viral membrane proteins, are transported to the assembly site on the plasma membrane where assembly, budding and virus release DAGC into the outside environment occur (reviewed in Nayak, 1996 Nayak, , 2000 . Consequently, various host components including PKs are intimately involved in regulating different aspects of the virus life-cycle (reviewed in Ludwig et al., 1999) . For example, the influenza virus entry into the attached cells requires PKC (Root et al., 2000) . PKC also plays a role in viral mRNA translation (Kurokawa et al., 1990) . The transport of RNPs into the nucleus is mediated by the α class of the karyopherin import receptor protein (reviewed in Portela & Digard, 2002) . RNP\M1 and NP in the cytoplasm associate with cytoskeletal components (Avalos et al., 1997) . A recent microarray-based gene expression study (Geiss et al., 2001) listed the up-and down-regulation of expression of many genes during the early (4 h p.i.) and late (8 h p.i.) phases of infection.
However, relatively little information is available on the involvement of host components in the budding process of enveloped viruses in general and influenza viruses in particular. Recently, a number of elegant studies have shown that the regulatory role of host components in the release of virus by budding in retroviruses (HIV, Rous sarcoma virus and equine infectious anaemia virus), vesicular stomatitis virus (VSV), rabies virus and Ebola viruses. The AP-50 subunit (medium chain) of cellular AP-2 clathrin-associated adaptor protein complex, the Yes-associated protein (Yap), the Nedd4-like family of E3 ubiquitin protein ligase and Tsg101 have been shown to be actively involved in the release of virus by budding. The majority of these viruses contain specific late domains (L domains) in the matrix proteins, which interact with cellular components (reviewed in Luban, 2001 ; Freed, 2002) . However, similar information is not yet available for influenza virus budding. Towards this goal, we have initiated studies for defining the role of different host components in influenza virus budding. We have developed a system to reconstitute the budding process by permeabilizing the polarized MDCK cells from the basal side, exchanging and introducing the cytosolic components from the basal side and assaying virus budding from the intact apical side ). Using such a system, we have recently shown that ATP is actively required for influenza virus budding and that ATP hydrolysis (and not just ATP binding) is required for the budding and release of virus particles.
In the present paper, we show that the G protein and CK2 also play a critical role in influenza virus budding. G proteins are known to play important roles in a number of cellular signals and the basic mechanism of G protein-mediated signal transduction is well understood. Different classes of G protein have been shown to be involved in apical versus basolateral transport in polarized epithelial cells. In virus-infected MDCK cells, the G s class of G proteins has been shown to be involved in the apical transport of HA, whereas G i proteins affected the basolateral transport of VSV G proteins (Pimplikar & Simons, 1993) . Our data show that GTP binding, which activates G protein signalling, is required for influenza virus budding. However, at present, the precise role of the G protein in influenza virus budding is unclear. Initiation of virus budding may involve processes similar to membrane ruffling, which is affected by cytoskeletal components and lipid rafts, as well as signal transduction by G proteins (see Ridley, 1994) . Furthermore, it is likely that the M1 protein can directly or indirectly interact with G proteins in initiating the budding process or releasing virus particles, since the expression of M1 protein alone can lead to the formation and release of virus-like particles (Go! mez-Puertas et al., 2000 ; Latham & Gularza, 2001) .
Host PKs are also actively involved in different steps of influenza virus replication and many studies on the effect of PK inhibitors during influenza virus replication have been carried out (Kurokawa et al., 1990 ; Martin & Helenius, 1991 ; Vogel et al., 1994 ; Neumann et al., 1997 ; Bui et al., 2000 ; Root et al., 2000 ; Pleschka et al., 2001 ). It appears that six of the ten influenza A virus proteins can be phosphorylated. These are NP (Petri & Dimmock, 1981 ; Almond & Felsenreich, 1982 ; Kistner et al., 1985 Kistner et al., , 1989 , NS1 (Petri et al., 1982) , M1 (Gregoriades et al., 1984 (Gregoriades et al., , 1990 , NEP\NS2 (Richardson & Akkina, 1991) , M2 (Holsinger et al., 1995) and PA (SanzEzquerro et al., 1998) . Although phosphorylated M1 and NP have been found in virus particles (Gregoriades et al., 1984) , there is no data showing a specific requirement for phosphorylation of any viral protein in the budding process. Among the viral proteins, M1 and PA have been shown to be phosphorylated by PKC (Reinhardt & Wolff, 2000) and CK2 (Perales et al., 2000) , respectively. Kinases involved in the phosphorylation of other viral proteins are as yet uncharacterized. However, our studies show that neither PKA nor PKC, which have been shown to affect different phases of virus replication (Kurokawa et al., 1990 ; Neumann et al., 1997 ; Root et al., 2000) , are involved in the budding process. CK2, on the other hand, appears to be actively involved in the budding process, since the CK2 activity was stimulated during the virus replication cycle, reaching a maximum during the budding phase, and specific inhibitors of CK2 decreased virus budding significantly.
CK2 is a ubiquitous eukaryotic Ser\Thr kinase present in the plasma membrane, cytoplasm, mitochondria and nucleus (reviewed in Faust & Montenarh, 2000) . This enzyme is cyclicnucleotide-independent and insensitive to calcium. CK2 is unusual among the PKs since it can use both ATP (K m 10 µM) and GTP (K m 20-30 µM) as phosphate donors. CK2 is known to phosphorylate more than a hundred cellular substrates, many of which are involved in regulating signal transduction pathways. Since virus budding is regulated by ATP, the membrane physical state, the G protein and PKs, as well as the cytoskeleton, the substrate(s) of CK2 during virus budding could be one or more of these components, including the cytoskeletal proteins, which interact with RNP\M1 complexes. Both membrane-bound and cytosolic CK2 phosphorylate many cytoskeletal proteins, such as spectrin, ankyrin, adducin, MAP-1B, tau and E-cadherin (reviewed in Allende & Allende, 1995 ; Faust & Montenarh, 2000) . Moreover, CK2 is also known to play a role in the regulation of membrane proximal signalling events (for a review, see Allende & Allende, 1995) .
The presence of CK2 in the influenza virion (Tucker et al., 1990 ; reviewed in Hui, 2002) suggests the possibility of CK2 presence in the vicinity of the budding area of influenza virus and its active involvement in the budding process. Some viruses (such as HIV and herpes simplex virus) have been shown to encapsidate cellular PKs, which play an important role in virus infectivity and virulence (for a review, see . However, the only known function of CK2 in influenza virus replication is to phosphorylate viral polymerase PA (Perales et al., 2000) , which is likely to occur during the RNA replication phase of the influenza virus life-cycle. Furthermore, this function of CK2 should be restricted to cell nuclei, which contain high levels of CK2 and where the virus replication\ transcription occurs. Therefore, the encapsidation of CK2 into influenza virus particles is not essential for PA phosphorylation and suggests a different role for CK2 function in the assembly and budding processes.
In summary, we have demonstrated that both G protein activity and CK2 function are critically involved in the budding process of influenza viruses. Influenza virus causes a serious worldwide health problem. Understanding more about viruscell interactions during the budding process could provide new targets for therapy and intervention in the disease process.
